Confirmatory analysis of firocoxib in bovine milk by rapid resolution liquid chromatography tandem mass spectrometry

被引:14
作者
Dowling, Geraldine [1 ]
Gallo, Pasquale [2 ]
Regan, Liam [1 ]
机构
[1] Stat Lab, Celbridge, Kildare, Ireland
[2] Ist Zooprofilat Sperimentale Mezzogiorno, I-80055 Naples, Italy
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 5-6期
关键词
Firocoxib; Bovine milk; Method validation; Decision limit; Detection capability; Mass spectrometry; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IN-VIVO EFFICACY; CYCLOOXYGENASE-2; INHIBITOR; HORSE;
D O I
10.1016/j.jchromb.2008.12.059
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid method has been developed to analyse for firocoxib (FIRO) residue in bovine milk. Milk samples were extracted with acetonitrile and sample extracts were purified on Evolute (TM) ABN solid phase extraction cartridges. Aliquots were analysed by rapid resolution liquid chromatography tandem mass spectrometry (RRLC-MS/MS). The method was validated in bovine milk, according to the criteria defined in Commission Decision 2002/657/EC. The decision limit (CC alpha) was 1.18 ng/mL and for the detection capability a (CC beta) value of 2.02 ng/mL was obtained. The measurement uncertainty of the method was 27%. Fortifying bovine milk samples (n = 18) in three separate assays, show the accuracy of the method to be between 96 and 105%. The precision of the method, expressed as RSD values for the within-lab reproducibility at the three levels of fortification (5, 7.5 and 10 ng/mL) was less than 11% respectively. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 13 条
  • [1] DEBABRATA M, 2008, CONGEST HEART FAIL, V14, P75
  • [2] DOUCET MY, 2008, J AM VET MED ASSOC, P91
  • [3] *EMEA, EMEAVC082
  • [4] LONG-TERM EXPOSURE TO THE ANTIINFLAMMATORY AGENT PHENYLBUTAZONE INDUCES KIDNEY TUMORS IN RATS AND LIVER-TUMORS IN MICE
    KARI, F
    BUCHER, J
    HASEMAN, J
    EUSTIS, S
    HUFF, J
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (03): : 252 - 263
  • [5] KOPCHA M, 1992, J AM VET MED ASSOC, V201, P1868
  • [6] Quantitative HPLC-UV method for the determination of firocoxib from horse and dog plasma
    Kvaternick, Valerie
    Malinski, Thomas
    Wortmann, Jill
    Fischer, James
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 854 (1-2): : 313 - 319
  • [7] Automated liquid chromatography-tandem mass spectrometry method for the analysis of firocoxib in urine and plasma from horse and dog
    Letendre, Laura
    Kvaternick, Valerie
    Tecle, Berhane
    Fischer, James
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 853 (1-2): : 333 - 345
  • [8] In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia
    McCann, ME
    Rickes, EL
    Hora, DE
    Cunningham, PK
    Zhang, DH
    Brideau, C
    Black, WC
    Hickey, GJ
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2005, 66 (07) : 1278 - 1284
  • [9] In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis
    McCann, ME
    Andersen, DR
    Zhang, DH
    Brideau, C
    Black, WC
    Hanson, PD
    Hickey, GJ
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2004, 65 (04) : 503 - 512
  • [10] *SANCO, SANCO20042726REV